View Author
stent patient group study restenosi follow-up circulation angioplasty month lesion stenting artery sirolimus-eluting implantation trial revascularization vessel balloon angioplasty result in-stent procedure balloon angiographic sirolimus-eluting stents treatment volume event neointimal stent implantation intravascular outcome ultrasound diameter sirolimu serruy analysis in-stent restenosis table percent target randomized lumen difference surgery sirolimus-eluting stent 12 months segment sousa angiography heart velocity stenosi percutaneou disease neointimal proliferation dissection angina apposition drug-eluting ravel value hyperplasia infarction death effect figure drug-eluting stents survival netherland abizaid proliferation target lesion diabetes cardiol 6 months rotterdam comparison intervention 1 year institute dante pazzanese
10 Most Recent Publications
|
Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial.
(Article)
Aoki, J. Ong, A.T.L. Lindeboom, W.K. Unger, F. Serruys, P.W.J.C. Hoye, A. Herwerden, L.A. van Sousa, J.E. Jatene, A. Bonnier, J.J.R.M. Schonberger, J.P.A.M. Buller, N. Bonser, R. |
2005-08-01
|
|
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
(Article)
Sousa, J.E. Costa, M.A. Sousa, A.G.M.R. Abizaid, A.C. Feres, F. Seixas, A.C. Tanajura, L.F. Mattos, L.A. Falotico, R. Jaeger, J. Popma, J.J. Serruys, P.W.J.C. |
2005-05-10
|
|
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
(Article)
Fajadet, J. Morice, M-C. Laarman, G-J. Perin, M.A. Sousa, J.E. Schuler, G. Molnar, F. Guagliumi, G. Colombo, A. Ban Hayashi, E. Wülfert, E. Barragan, P. Serruys, P.W.J.C. Wijns, W. Constantini, C. Guermonprez, J-L. Eltchaninoff, H. Blanchard, D. Bartorelli, A. |
2005-03-01
|
|
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
(Article)
Serruys, P.W.J.C. Ormiston, J.A. Thuesen, L. Zeiher, A.M. Bett, J.H. Suttorp, M.J. Glogar, H.D. Pitney, M. Wilkins, G.T. Whitbourn, R. Veldhof, S. Miquel, K. Sianos, G. Johnson, R. Coleman, L. Virmani, R. Feyter, P.J. de Sousa, J.E. Grube, E. Heijer, P. den Buszman, P. Schomig, A. Marco, J. Polonski, L. |
2004-10-06
|
|
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions
(Article)
Degertekin, M. Feyter, P.J. de Regar, E.S. Sianos, G. Abizaid, A.C. Popma, J.J. Wülfert, E. Lemos, P.A. Lee, C.H. Tanabe, K. Sousa, J.E. Serruys, P.W.J.C. Giessen, W.J. van der |
2004-01-01
|
|
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial
(Article)
Eltchaninoff, H. Guagliumi, G. Blanchard, D. Serruys, P.W.J.C. Abizaid, A.C. Albertal, M. Laarman, G-J. Morice, M-C. Abizaid, A.S. Sousa, A.G.M.R. Wülfert, E. Sousa, J.E. Lindeboom, W.K. Costa, M.A. |
2004-01-01
|
|
Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
(Article)
Degertekin, M. Serruys, P.W.J.C. Tanabe, K. Lee, C.H. Sousa, J.E. Colombo, A. Morice, M-C. Ligthart, J.M.R. Feyter, P.J. de |
2003-12-02
|
|
Drug-eluting stents: cost versus clinical benefit.
(Article)
Lemos, P.A. Serruys, P.W.J.C. Sousa, J.E. |
2003-06-24
|
|
New frontiers in cardiology: drug-eluting stents: Part I.
(Article)
Sousa, J.E. Serruys, P.W.J.C. Costa, M.A. |
2003-05-06
|
|
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study
(Article)
Sousa, J.E. Feres, F. Costa, M.A. Sousa, A.G.M.R. Serruys, P.W.J.C. Abizaid, A.C. Mattos, L.A. Centemero, M. Maldonado, G. Abizaid, A.S. Popma, J.J. Pinto, I.M.F. Jaeger, J. Falotico, R. |
2003-01-01
|
